WHO approves Chinese COVID-19 vaccine for emergency use
The UN agency has approved the Sinopharm vaccine for emergency use, which is a prerequisite for inclusion in the global vaccine solidarity initiative, COVAX.
The vaccine is easy to store, making it suitable for locations with limited resources, and proved 79 per cent effective in clinical trials.
“The addition of this vaccine has the potential to rapidly accelerate COVID-19 vaccine access for countries seeking to protect health workers and populations at risk”, said Dr Mariângela Simão, WHO Assistant-Director General for Access to Health Products.
“We urge the manufacturer to participate in the COVAX Facility and contribute to the goal of more equitable vaccine distribution.”
A vaccine first
The Sinopharm vaccine is produced by Beijing Bio-Institute of Biological Products Co Ltd, a subsidiary of China National Biotec Group (CNBG).
It is the first vaccine to carry a vaccine vial monitor. The vials have a small sticker that changes colour as the vaccine is exposed to heat, so health workers know whether it can be safely used.
The vaccine is recommended for adults 18 and older, with a two-dose schedule spaced over a period of three to four weeks.
Although few people over 60 participated in the clinical trials, WHO did not recommend an upper age limit for use as data suggests the vaccine is likely to have a protective effect in older persons.
Safely expediting vaccines
WHO emergency use listing (EUL) allows countries to expedite their own regulatory approval to import and administer COVID-19 vaccines.
The EUL process assesses the suitability of new medicines, vaccines and diagnostics during public health emergencies.
The goal is to make them available as rapidly as possible, while maintaining strict criteria of safety, efficacy and quality.
The Sinopharm vaccine is the sixth to receive the EUL approval. The others are by Pfizer/BioNTech, Astrazeneca-SK Bio, Serum Institute of India, Janssen (Johnson & Johnson) and Moderna.
© UN News (2021) — All Rights ReservedOriginal source: UN News
Where next?
Browse related news topics:
Read the latest news stories:
- Civil Society Scores LGBTQI+ Rights Victory in Dominica Monday, May 06, 2024
- 1.8 Million More Palestinians Doomed to Poverty if Gaza War Persists Monday, May 06, 2024
- LDCs Need Concessional Grants, Not Loans, Say Experts Monday, May 06, 2024
- Peace or war, midwives keep delivering Sunday, May 05, 2024
- Trafficking in the Sahel: Cracking down on illicit drugs Sunday, May 05, 2024
- First Person: Women in Madagascar too ashamed to seek help giving birth Sunday, May 05, 2024
- ‘Moral obligation’ of Haitian NGO worker to carry on despite kidnapping of two children Saturday, May 04, 2024
- ‘Our voices need to be included’: Trinidadian youth make case for strong role in climate negotiations Saturday, May 04, 2024
- Media Freedom Declining Across Europe, With Implications for Rule of Law Friday, May 03, 2024
- Pillay: Israel is helped by ‘powerful States’ in violation of Palestinians’ rights Friday, May 03, 2024
Learn more about the related issues: